“`html
BRUSSELS, February 26, 2026 – A biotech startup just landed €4 million to peer inside living cells like never before. QT Sense, a deep-tech company, is poised to accelerate growth of its Quantum nuova platform, a technology that visualizes cellular processes in real time and could unlock new understandings of disease.
Unlocking Cellular Secrets with Quantum Sensing
The funding will help QT Sense refine a platform offering unprecedented views of biochemical activity within cells.
- QT Sense secured €4 million in funding to advance its Quantum Nuova platform.
- The funding round was led by Cottonwood Technology Fund with participation from QDNL Participations and an angel investor.
- An additional €1 million came from the ONCO-Q program and the Quantum Forward Challenge.
- the technology aims to reveal biochemical activity linked to disease by observing cells in real time.
The €4 million investment includes a €3 million seed investment spearheaded by Cottonwood Technology Fund, alongside follow-on support from QDNL Participations and a private angel investor. QT Sense also received €600,000 from the ONCO-Q programme, dedicated to cancer research, and an additional €400,000 through the Quantum Forward Challenge, designed to foster collaborative research deployments.
What makes this technology different? Most customary lab methods rely on indirect measurements or snapshots in time, frequently enough disrupting the very processes they aim to study. Quantum Nuova promises a non-invasive, real-time view of what’s happening inside cells, potentially revolutionizing drug finding and disease understanding.
Quantum sensing leverages the principles of quantum mechanics to detect incredibly subtle changes in a cell’s habitat, offering a level of sensitivity far beyond conventional techniques.
The company plans to use the funding to refine the Quantum Nuova platform and expand its collaborations with research institutions. The potential applications span a wide range of diseases, from cancer to neurodegenerative disorders, offering a new lens through which to investigate the complexities of life at the cellular level.
The Promise of Real-Time Observation
Traditional methods often require fixing cells or using fluorescent markers, which can alter their natural behavior. Quantum Nuova aims to overcome these limitations by providing a truly dynamic view of cellular processes, allowing scientists to observe how cells respond to stimuli and interact with their environment in real time.
Did you know?– Quantum sensing is a rapidly developing field, with potential applications extending beyond biology into materials science and environmental monitoring.
The Quantum Forward Challenge funding will specifically support collaborative projects, enabling researchers to test and refine the platform in real-world settings. This collaborative approach is crucial for ensuring that the technology meets the needs of the scientific community and accelerates its adoption.
The ONCO-Q programme funding will focus on applying the Quantum Nuova platform to cancer research, potentially leading to earlier detection and more effective treatments. Why did this happen? The funding reflects growing recognition of the potential of quantum technology to address major challenges in healthcare.Who is involved? QT Sense, Cottonwood Technology Fund, QDNL Participations, an angel investor, the ONCO-Q programme, and researchers participating in the Quantum Forward Challenge.What is the technology? Quantum Nuova,a platform using quantum sensing to visualize cellular processes in real time. How did it end? The funding round closed successfully,providing QT Sense with €4 million to advance its platform and collaborate with research institutions.
Pro tip– When evaluating biotech investments,consider the potential for disruption and the strength of the underlying science. Quantum Nuova’s non-invasive
